Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog
about
PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literatureNovel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study
P2860
Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Switch from antagonist to agon ...... lator to a somatostatin analog
@ast
Switch from antagonist to agon ...... lator to a somatostatin analog
@en
Switch from antagonist to agon ...... lator to a somatostatin analog
@nl
type
label
Switch from antagonist to agon ...... lator to a somatostatin analog
@ast
Switch from antagonist to agon ...... lator to a somatostatin analog
@en
Switch from antagonist to agon ...... lator to a somatostatin analog
@nl
prefLabel
Switch from antagonist to agon ...... lator to a somatostatin analog
@ast
Switch from antagonist to agon ...... lator to a somatostatin analog
@en
Switch from antagonist to agon ...... lator to a somatostatin analog
@nl
P2093
P2860
P1476
Switch from antagonist to agon ...... lator to a somatostatin analog
@en
P2093
Beatrice Waser
Jean E Rivier
Judit Erchegyi
Renzo Cescato
P2860
P2888
P304
P356
10.1007/S00259-010-1445-X
P577
2010-04-16T00:00:00Z